Daan Biotherapeutics
PrivateLast Round
Series A
Jan 25, 2024
Est. Valuation
$20.5M
Total Funding Raised
$21.3M
Company Overview
Daan Biotherapeutics operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series A round in January 2024.
Daan Biotherapeutics is a biotechnology company that develops treatments for cancer including cell therapies, antibodies, and small molecule inhibitors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Daan Biotherapeutics Comparables
Compare Daan Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| T-Knife | 89% | |
| Immatics N.V. | 81% | |
| LEO Pharma | 81% |
For institutional investors. Book with your work email.
Daan Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 25, 2024 | ||||
| Seed | Mar 28, 2022 |
For institutional investors. Book with your work email.
Daan Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Company K Partners, Limited | Series A |
| DAYLI Partners | Series A |
| Paratus Investment | Series A |
| KB Investment | Series A |
| Timefolio Asset Management | Seed, Series A |
| Company K Partners | Seed |
| FuturePlay | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 25, 2024
$17M round led by Paratus Investment and Timefolio Asset Management.
- Mar 28, 2022
$4M round with participation from Timefolio Asset Management and Company K Partners.
For institutional investors. Book with your work email.
Daan Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Daan Biotherapeutics's valuation, stock price, and market status.
Is Daan Biotherapeutics a public or private company?
Daan Biotherapeutics is a private company.
What is the current stock price of Daan Biotherapeutics?
Daan Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks Daan Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Daan Biotherapeutics worth (valuation)?
Daan Biotherapeutics's valuation is estimated at $20.5M based on funding round data.
Can I buy Daan Biotherapeutics stock?
Daan Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Daan Biotherapeutics's last funding round?
Daan Biotherapeutics's most recent funding round was Series A on January 25, 2024.
Who are the main investors in Daan Biotherapeutics?
Key investors in Daan Biotherapeutics include Company K Partners, Limited, Paratus Investment, Timefolio Asset Management, Solasta Ventures.
Will Daan Biotherapeutics IPO soon?
No public IPO plans have been announced for Daan Biotherapeutics.
How can I track Daan Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Daan Biotherapeutics's shares on secondary markets.